• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对丙型肝炎有效的功能性食品:低聚原花青素的鉴定及其作用机制。

Functional foods effective for hepatitis C: Identification of oligomeric proanthocyanidin and its action mechanism.

作者信息

Ishida Yo-Ichi, Takeshita Masahiko, Kataoka Hiroaki

机构信息

Yo-ichi Ishida, Department of Molecular and Cellular Biochemistry, Meiji Pharmaceutical University, Kiyose, Tokyo 204-8588, Japan.

出版信息

World J Hepatol. 2014 Dec 27;6(12):870-9. doi: 10.4254/wjh.v6.i12.870.

DOI:10.4254/wjh.v6.i12.870
PMID:25544874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4269906/
Abstract

Hepatitis C virus (HCV) is a major cause of viral hepatitis and currently infects approximately 170 million people worldwide. An infection by HCV causes high rates of chronic hepatitis (> 75%) and progresses to liver cirrhosis and hepatocellular carcinoma ultimately. HCV can be eliminated by a combination of pegylated α-interferon and the broad-spectrum antiviral drug ribavirin; however, this treatment is still associated with poor efficacy and tolerability and is often accompanied by serious side-effects. While some novel direct-acting antivirals against HCV have been developed recently, high medical costs limit the access to the therapy in cost-sensitive countries. To search for new natural anti-HCV agents, we screened local agricultural products for their suppressive activities against HCV replication using the HCV replicon cell system in vitro. We found a potent inhibitor of HCV RNA expression in the extracts of blueberry leaves and then identified oligomeric proanthocyanidin as the active ingredient. Further investigations into the action mechanism of oligomeric proanthocyanidin suggested that it is an inhibitor of heterogeneous nuclear ribonucleoproteins (hnRNPs) such as hnRNP A2/B1. In this review, we presented an overview of functional foods and ingredients efficient for HCV infection, the chemical structural characteristics of oligomeric proanthocyanidin, and its action mechanism.

摘要

丙型肝炎病毒(HCV)是病毒性肝炎的主要病因,目前全球约有1.7亿人感染该病毒。HCV感染会导致慢性肝炎的高发病率(>75%),最终发展为肝硬化和肝细胞癌。聚乙二醇化α干扰素和广谱抗病毒药物利巴韦林联合使用可清除HCV;然而,这种治疗方法的疗效和耐受性仍然较差,且常伴有严重的副作用。虽然最近开发了一些新型的抗HCV直接作用抗病毒药物,但高昂的医疗成本限制了成本敏感型国家获得该疗法的机会。为了寻找新的天然抗HCV药物,我们利用HCV复制子细胞系统在体外筛选了当地农产品对HCV复制的抑制活性。我们在蓝莓叶提取物中发现了一种有效的HCV RNA表达抑制剂,随后鉴定出低聚原花青素为活性成分。对低聚原花青素作用机制的进一步研究表明,它是一种异质性核糖核蛋白(hnRNPs)如hnRNP A2/B1的抑制剂。在这篇综述中,我们概述了对HCV感染有效的功能性食品和成分、低聚原花青素的化学结构特征及其作用机制。

相似文献

1
Functional foods effective for hepatitis C: Identification of oligomeric proanthocyanidin and its action mechanism.对丙型肝炎有效的功能性食品:低聚原花青素的鉴定及其作用机制。
World J Hepatol. 2014 Dec 27;6(12):870-9. doi: 10.4254/wjh.v6.i12.870.
2
Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA.蓝莓叶中的原花青素可抑制丙型肝炎病毒亚基因组RNA的表达。
J Biol Chem. 2009 Aug 7;284(32):21165-76. doi: 10.1074/jbc.M109.004945. Epub 2009 Jun 16.
3
Inhibitory effects of Pycnogenol® on hepatitis C virus replication.碧萝芷对丙型肝炎病毒复制的抑制作用。
Antiviral Res. 2015 Jan;113:93-102. doi: 10.1016/j.antiviral.2014.10.017. Epub 2014 Nov 20.
4
Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.基于活性和组分导向的叶下珠分析确定了黑麦草内酯是丙型肝炎病毒进入的有效抑制剂。
Antiviral Res. 2016 Jun;130:58-68. doi: 10.1016/j.antiviral.2016.03.012. Epub 2016 Mar 21.
5
[Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].[聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎病毒感染期间加用或不加用蛋白酶抑制剂直接抗病毒药物的副作用]
Orv Hetil. 2011 Dec 11;152(50):1997-2009. doi: 10.1556/OH.2011.29266.
6
Gene therapies for hepatitis C virus.丙型肝炎病毒的基因疗法
Adv Exp Med Biol. 2015;848:1-29. doi: 10.1007/978-1-4939-2432-5_1.
7
Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.荷叶提取物及其生物活性成分抗肝炎 C 病毒活性及在感染肝细胞中的协同作用。
Microb Pathog. 2018 Aug;121:198-209. doi: 10.1016/j.micpath.2018.05.023. Epub 2018 May 31.
8
Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.现代药物研发中的挑战:以博赛匹韦为例,一种用于治疗丙型肝炎病毒感染的HCV蛋白酶抑制剂
Acc Chem Res. 2008 Jan;41(1):50-9. doi: 10.1021/ar700109k.
9
New direct-acting antivirals' combination for the treatment of chronic hepatitis C.新型直接作用抗病毒药物联合治疗慢性丙型肝炎。
Liver Int. 2011 Jan;31 Suppl 1:68-77. doi: 10.1111/j.1478-3231.2010.02411.x.
10
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.

引用本文的文献

1
Natural Immunomodulatory Agents as a Complementary Therapy for Poxviruses.天然免疫调节剂作为痘病毒的辅助治疗方法。
Adv Exp Med Biol. 2024;1451:337-354. doi: 10.1007/978-3-031-57165-7_22.
2
An update on the development of antiviral against Mayaro virus: from molecules to potential viral targets.关于抗梅里亚病毒抗病毒药物研发的最新进展:从分子到潜在的病毒靶点。
Arch Microbiol. 2023 Mar 7;205(4):106. doi: 10.1007/s00203-023-03441-y.
3
Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins.应对未来的大流行:基于 A 型原花青素的广谱抗病毒药物(BSAAs)。
Molecules. 2022 Nov 30;27(23):8353. doi: 10.3390/molecules27238353.
4
A composite carbon-based solid acid-supported palladium catalyst (Pd/C-SOH) for hydrogenolysis of plant-derived polymeric proanthocyanidins.一种用于植物源聚合原花青素氢解的复合碳基固体酸负载钯催化剂(Pd/C-SOH)。
RSC Adv. 2020 Jun 1;10(35):20665-20675. doi: 10.1039/d0ra03518a. eCollection 2020 May 27.
5
Molecular Mechanism and Health Role of Functional Ingredients in Blueberry for Chronic Disease in Human Beings.蓝莓中功能性成分在人类慢性病中的分子机制和健康作用。
Int J Mol Sci. 2018 Sep 16;19(9):2785. doi: 10.3390/ijms19092785.
6
Cynaropicrin: A Comprehensive Research Review and Therapeutic Potential As an Anti-Hepatitis C Virus Agent.洋艾素:作为一种抗丙型肝炎病毒药物的综合研究综述及治疗潜力
Front Pharmacol. 2016 Dec 8;7:472. doi: 10.3389/fphar.2016.00472. eCollection 2016.
7
In Vitro Study on Anti-Hepatitis C Virus Activity of Spatholobus suberectus Dunn.鸡血藤抗丙型肝炎病毒活性的体外研究
Molecules. 2016 Oct 15;21(10):1367. doi: 10.3390/molecules21101367.
8
(+)-Catechin inhibition of transmissible gastroenteritis coronavirus in swine testicular cells is involved its antioxidation.(+)-儿茶素对猪睾丸细胞中传染性胃肠炎冠状病毒的抑制作用涉及其抗氧化作用。
Res Vet Sci. 2015 Dec;103:28-33. doi: 10.1016/j.rvsc.2015.09.009. Epub 2015 Sep 12.
9
Pan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian Artichoke.源自野生埃及洋蓟的天然产物对全基因型丙型肝炎病毒的抑制作用
J Virol. 2015 Dec 9;90(4):1918-30. doi: 10.1128/JVI.02030-15. Print 2016 Feb 15.
10
Dietary polyphenols in prevention and treatment of prostate cancer.膳食多酚在前列腺癌防治中的作用
Int J Mol Sci. 2015 Feb 3;16(2):3350-76. doi: 10.3390/ijms16023350.

本文引用的文献

1
Oral antiviral therapies for chronic hepatitis C infection.用于慢性丙型肝炎感染的口服抗病毒疗法。
Ther Adv Infect Dis. 2013 Jun;1(3):107-16. doi: 10.1177/2049936113488359.
2
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study.达拉他韦联合asunaprevir 治疗 1b 型丙型肝炎病毒:一项多中心、3 期、多队列研究。
Lancet. 2014 Nov 1;384(9954):1597-605. doi: 10.1016/S0140-6736(14)61059-X. Epub 2014 Jul 28.
3
Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.丙型肝炎病毒异质性对干扰素敏感性的影响:综述
World J Gastroenterol. 2014 Jun 28;20(24):7555-69. doi: 10.3748/wjg.v20.i24.7555.
4
Small molecule inhibitors of HCV replication from pomegranate.来自石榴的丙型肝炎病毒复制小分子抑制剂。
Sci Rep. 2014 Jun 24;4:5411. doi: 10.1038/srep05411.
5
Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.西美瑞韦联合聚乙二醇干扰素 α-2a 或 -2b 加利巴韦林治疗初治慢性丙型肝炎病毒基因 1 型感染患者(QUEST-2):一项随机、双盲、安慰剂对照的 3 期临床试验。
Lancet. 2014 Aug 2;384(9941):414-26. doi: 10.1016/S0140-6736(14)60538-9. Epub 2014 Jun 4.
6
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.来迪派韦索磷布韦片与索磷布韦联用治疗初治的 HCV 基因 1 型感染。
N Engl J Med. 2014 May 15;370(20):1889-98. doi: 10.1056/NEJMoa1402454. Epub 2014 Apr 11.
7
hnRNP L and NF90 interact with hepatitis C virus 5'-terminal untranslated RNA and promote efficient replication.异质性核糖核蛋白L和NF90与丙型肝炎病毒5'-末端非编码RNA相互作用并促进高效复制。
J Virol. 2014 Jul;88(13):7199-209. doi: 10.1128/JVI.00225-14. Epub 2014 Apr 9.
8
Review article: HCV genotype 3 – the new treatment challenge.综述文章:丙型肝炎病毒基因3型——新的治疗挑战
Aliment Pharmacol Ther. 2014 Apr;39(7):686-98. doi: 10.1111/apt.12646.
9
A randomized trial of daclatasvir with peginterferon alfa-2b and ribavirin for HCV genotype 1 infection.一项针对丙型肝炎病毒1型感染,使用达卡他韦联合聚乙二醇干扰素α-2b及利巴韦林的随机试验。
Antivir Ther. 2014;19(5):491-9. doi: 10.3851/IMP2730. Epub 2014 Jan 22.
10
Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.无干扰素治疗丙型肝炎病毒基因型 1 的 2b 期临床试验。
N Engl J Med. 2014 Jan 16;370(3):222-32. doi: 10.1056/NEJMoa1306227.